Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Tumor Biology

Volumn 36, Issue 11, 2015, Pages 8349-8357

  Li, An Chuan ^a,b   Xiao, Wei Wei ^a   Wang, Lin ^a   Shen, Guan Zhu ^a   Xu, An An ^a,c   Cao, Yan Qing ^a,d   Huang, Shao Min ^a   Lin, Cheng Guang ^a   Han, Fei ^a   Deng, Xiao Wu ^a   Zhao, Chong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Distant metastasis; Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Prediction score model

Indexed keywords

ALBUMIN; CISPLATIN; GLOBULIN; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; DISTANT METASTASIS; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NEUTROPHIL LYMPHOCYTE RATIO; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; CANCER STAGING; METASTASIS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS;

EID: 84949100984     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3574-0     Document Type: Article

References (46)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–9.
2. Zhao C, Xiao W, Han F, Lu L, Wu S, et al. Long-term outcome and prognostic factors of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Chin J Radiat Oncol. 2010;19:191–6.
3. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–50.
4. Lee N, Harris J, Garden AS, Straube W, Glisson B, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27:3684–90.
5. Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79:420–8.
6. Sun X, Su S, Chen C, Han F, Zhao C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398–403.
7. Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, et al. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010;46:1967–78.
8. Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:79–85.
9. Yu E, O'Sullivan B, Kim J, Siu L, Bartlett E. Magnetic resonance imaging of nasopharyngeal carcinoma. Expert Rev Anticancer Ther. 2010;10:365–75.
10. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22.
11. Qiu MZ, Xu RH, Ruan DY, Li ZH, Luo HY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010;31:633–41.
12. Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, et al. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. Int J Radiat Oncol Biol Phys. 2012;82:e359–65.
13. Xiao WW, Huang SM, Han F, Wu SX, Lu LX, et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer. 2011;117:1874–83.
14. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
15. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009;12:444–54.
16. Wu Z, Su Y, Zeng RF, Gu MF, Huang SM. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy. J Cancer Res Clin Oncol. 2014;140:69–76.
17. Lee CC, Huang TT, Lee MS, Hsiao SH, Lin HY, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome. Radiat Oncol. 2010;5:20.
18. Guo R, Sun Y, Yu XL, Yin WJ, Li WF, et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol. 2012;104:294–9.
19. Chua DT, Sham JS, Kwong DL, Tai KS, Wu PM, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys. 1997;39:711–9.
20. Chen MK, Chen TH, Liu JP, Chang CC, Chie WC. Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer. 2004;100:2160–6.
21. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131–46.
22. Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys. 1995;33:281–7.
23. Lartigau E, Le Ridant AM, Lambin P, Weeger P, Martin L, et al. Oxygenation of head and neck tumors. Cancer. 1993;71:2319–25.
24. Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, et al. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1993;26:631–6.
25. Yaes RJ. Tumor heterogeneity, tumor size, and radioresistance. Int J Radiat Oncol Biol Phys. 1989;17:993–1005.
26. Bentzen SM, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 1991;20:1197–206.
27. Hill RP, De Jaeger K, Jang A, Cairns R. PH, hypoxia and metastasis. Novartis Found Symp. 2001;240:154–65.
28. De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, et al. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int J Radiat Oncol Biol Phys. 1998;42:717–21.
29. Huang PY, Wang CT, Cao KJ, Guo X, Guo L, et al. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial. Eur J Cancer. 2013;49:1923–31.
30. Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99:999–1005.
31. Gao J, Tao YL, Li G, Yi W, Xia YF. Involvement of difference in decrease of hemoglobin level in poor prognosis of stage I and II nasopharyngeal carcinoma: implication in outcome of radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:1471–8.
32. Chang H, Gao J, Xu BQ, Guo SP, Lu RB, et al. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution. Clin Oncol (R Coll Radiol). 2013;25:639–46.
33. Wan S, Lai Y, Myers RE, Li B, Palazzo JP, et al. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies—results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers. BMC Cancer. 2013;13:340.
34. Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol. 2008;25:12–21.
35. Seaton K. Albumin concentration controls cancer. J Natl Med Assoc. 2001;93:490–3.
36. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.
37. Li G, Gao J, Liu ZG, Tao YL, Xu BQ, et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: long-term outcomes of 512 patients from a single institution. Head Neck. 2014;36:660–6.
38. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004;350:2461–70.
39. Gourzones C, Barjon C, Busson P. Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol. 2012;22:127–36.
40. An X, Ding PR, Wang FH, Jiang WQ, Li YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol. 2011;32:317–24.
41. Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.
42. Li G, Gao J, Tao YL, Xu BQ, Tu ZW, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Radiat Oncol. 2012;31:197–206.
43. Jin Y, Cai XY, Cai YC, Cao Y, Xia Q, et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area. Eur J Cancer. 2012;48:882–8.
44. Wang W, Feng M, Fan Z, Li J, Lang J. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014;2014:814948.
45. Cheng SH, Tsai SY, Horng CF, Yen KL, Jian JJ, et al. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:992–1003.
46. Tang LQ, Chen QY, Fan W, Liu H, Zhang L, et al. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2013;31:2861–9.